Marcel Pascal Konrad - Net Worth and Insider Trading
Marcel Pascal Konrad Net Worth
The estimated net worth of Marcel Pascal Konrad is at least $82,376 dollars as of 2025-07-16. Marcel Pascal Konrad is the Senior Officer of Medexus Pharmaceuticals Inc and owns about 29,420 shares of Medexus Pharmaceuticals Inc (TSX:MDP) stock worth over $82,376. Details can be seen in Marcel Pascal Konrad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marcel Pascal Konrad has not made any transactions after 2023-06-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Marcel Pascal Konrad
Marcel Pascal Konrad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marcel Pascal Konrad owns 1 companies in total, including Medexus Pharmaceuticals Inc (TSX:MDP) .
Click here to see the complete history of Marcel Pascal Konrad’s form 4 insider trades.
Insider Ownership Summary of Marcel Pascal Konrad
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
TSX:MDP | Medexus Pharmaceuticals Inc | 2023-06-23 | Senior Officer |
Marcel Pascal Konrad Latest Holdings Summary
Marcel Pascal Konrad currently owns a total of 1 stock. Marcel Pascal Konrad owns 29,420 shares of Medexus Pharmaceuticals Inc (TSX:MDP) as of June 23, 2023, with a value of $82,376.
Latest Holdings of Marcel Pascal Konrad
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:MDP | Medexus Pharmaceuticals Inc | 2023-06-23 | 29,420 | 2.80 | 82,376 |
Holding Weightings of Marcel Pascal Konrad
Marcel Pascal Konrad Form 4 Trading Tracker
According to the SEC Form 4 filings, Marcel Pascal Konrad has made a total of 6 transactions in Medexus Pharmaceuticals Inc (TSX:MDP) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Medexus Pharmaceuticals Inc is the acquisition of 5,100 shares on June 23, 2023, which cost Marcel Pascal Konrad around $7,249.
Insider Trading History of Marcel Pascal Konrad
- 1
Marcel Pascal Konrad Trading Performance
GuruFocus tracks the stock performance after each of Marcel Pascal Konrad's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marcel Pascal Konrad is 39.16%. GuruFocus also compares Marcel Pascal Konrad's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marcel Pascal Konrad within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Marcel Pascal Konrad's insider trading performs compared to the benchmark.
Performance of Marcel Pascal Konrad
Marcel Pascal Konrad Ownership Network
Ownership Network List of Marcel Pascal Konrad
Ownership Network Relation of Marcel Pascal Konrad

Marcel Pascal Konrad Owned Company Details
What does Medexus Pharmaceuticals Inc do?
Who are the key executives at Medexus Pharmaceuticals Inc?
Marcel Pascal Konrad is the Senior Officer of Medexus Pharmaceuticals Inc. Other key executives at Medexus Pharmaceuticals Inc include Senior Officer Brendon Buschman , Director & Senior Officer Kenneth d'Entremont , and Senior Officer Michael David Adelman .
Medexus Pharmaceuticals Inc (TSX:MDP) Insider Trades Summary
Over the past 18 months, Marcel Pascal Konrad made no insider transaction in Medexus Pharmaceuticals Inc (TSX:MDP). Other recent insider transactions involving Medexus Pharmaceuticals Inc (TSX:MDP) include a net purchase of 35,000 shares made by Brendon Buschman , a net sale of 0 shares made by Mike Mueller , and a net purchase of 3,200 shares made by Benoit Gravel .
In summary, during the past 3 months, insiders sold 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,500 shares of Medexus Pharmaceuticals Inc (TSX:MDP) were sold and 41,700 shares were bought by its insiders, resulting in a net purchase of 38,200 shares.
Medexus Pharmaceuticals Inc (TSX:MDP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Medexus Pharmaceuticals Inc Insider Transactions
Marcel Pascal Konrad Mailing Address
Above is the net worth, insider trading, and ownership report for Marcel Pascal Konrad. Currently GuruFocus does not have mailing address information for Marcel Pascal Konrad.